Analysis of Key Elements in Informed Consent Forms for Biobanks

Mingtao HUANG, Xiaomei ZHAI

Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (2) : 302-308.

PDF(923 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(923 KB)
Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (2) : 302-308. DOI: 10.3881/j.issn.1000-503X.16823
Medical Ethics

Analysis of Key Elements in Informed Consent Forms for Biobanks

Author information +
History +

Abstract

With the rapid development of biomedical research in China,biobanks have been widely established as crucial infrastructure supporting precision medicine and big data research.However,at the practical level,informed consent—central to safeguarding the rights and interests of research participants—often shows a disconnection between ethical principles and technological realities.This study first examines the Chinese translation of the term “biobank”, arguing that “biological sample data bank” better reflects both the data-centric nature and governance complexity of such entities.It then systematically reviews the ethical debates surrounding various models of informed consent,including blanket consent,broad consent,dynamic consent,and meta-consent.Building on this analysis,this paper identifies key ethical elements that an effective informed consent form should include.Special attention is paid to the legitimacy and practical challenges of components such as research purpose,data collection,data use,storage duration,risk disclosure,and return of results.This study aims to provide an ethical foundation and practical guidance for improving the informed consent framework in China’s biobank governance,thereby promoting a shift from mere regulatory compliance to robust ethical engagement and fostering a virtuous cycle between public trust and sustainable research development.

Key words

biobank / informed consent / data privacy / ethical governance

Cite this article

Download Citations
Mingtao HUANG , Xiaomei ZHAI. Analysis of Key Elements in Informed Consent Forms for Biobanks[J]. Acta Academiae Medicinae Sinicae. 2026, 48(2): 302-308 https://doi.org/10.3881/j.issn.1000-503X.16823

References

[1]
Chalmers D, Nicol D, Kaye J, et al. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era[J]. BMC Med Ethics, 2016, 17(1):39.DOI:10.1186/s12910-016-0124-2.
[2]
Vayena E, Dzenowagis J, Brownstein JS, et al. Policy implications of big data in the health sector[J]. Bull World Health Organ, 2018, 96(1):66-68.DOI:10.2471/BLT.17.197426.
[3]
杨亚军, 石宇辉, 王国豫. 人类生物样本库面临的伦理挑战及应对[J]. 中国科学:生命科学, 2024, 54(6):976-986.DOI:10.1360/SSV-2023-0074.
[4]
Choudhury S, Fishman JR, McGowan ML, et al. Big data,open science and the brain:lessons learned from genomics[J]. Front Hum Neurosci, 2014, 8:239.DOI:10.3389/fnhum.2014.00239.
[5]
雷瑞鹏, 邱仁宗. 数据共享是道德律令[J]. 自然辩证法研究, 2018, 34(1):45-50.DOI:10.19484/j.cnki.1000-8934.2018.01.009.
[6]
刘闵, 翟晓梅, 邱仁宗. 生物信息库的知情同意问题[J]. 中国医学伦理学, 2009, 22(2):31-33.DOI:10.3969/j.issn.1001-8565.2009.02.012.
[7]
OECD. Creation and governance of human genetic research databases[M]. Paris: OECD Publishing, 2006.
[8]
Council for International Organizations of Medical Sciences. International ethical guidelines for health-related research involving humans:prepared by the Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)[M]. Geneva: Council for International Organizations of Medical Sciences, 2016.
[9]
Hewitt R, Watson P. Defining biobank[J]. Biopreserv Biobank, 2013, 11(5):309-315.DOI:10.1089/bio.2013.0042.
[10]
Nielsen MEJ, Kongsholm NCH. Blanket consent and trust in the biobanking context[J]. J Bioeth Inq, 2022, 19(4):613-623.DOI:10.1007/s11673-022-10208-5.
[11]
Faden RR, Beauchamp TL. A history and theory of informed consent[M]. Oxford: Oxford University Press, 1986.
[12]
Kongsholm NCH, Kappel K. Is consent based on trust morally inferior to consent based on information[J]. Bioethics, 2017, 31(6):432-442.DOI:10.1111/bioe.12342.
[13]
Mikkelsen RB, Gjerris M, Waldemar G, et al. Broad consent for biobanks is best-provided it is also deep[J]. BMC Med Ethics, 2019, 20(1):71.DOI:10.1186/s12910-019-0414-6.
[14]
Grady C, Eckstein L, Berkman B, et al. Broad consent for research with biological samples:workshop conclusions[J]. Am J Bioeth, 2015, 15(9):34-42.DOI:10.1080/15265161.2015.1062162.
[15]
Manson NC. The biobank consent debate:why ‘meta-consent’ is not the solution[J]. J Med Ethics, 2019, 45(5):291-294. DOI:10.1136/medethics-2018-105007.
[16]
Kaye J, Whitley EA, Lund D, et al. Dynamic consent:a patient interface for twenty-first century research networks[J]. Eur J Hum Genet, 2015, 23(2):141-146.DOI:10.1038/ejhg.2014.71.
[17]
Whitley EA, Kanellopoulou N, Kaye J. Consent and research governance in biobanks:evidence from focus groups with medical researchers[J]. Public Health Genomics, 2012, 15(5):232-242.DOI:10.1159/000336544.
[18]
Steinsbekk KS, Kåre Myskja B, Solberg B. Broad consent versus dynamic consent in biobank research:is passive participation an ethical problem[J]. Eur J Hum Genet, 2013, 21(9):897-902.DOI:10.1038/ejhg.2012.282.
[19]
Wolf LE, Lo B. Untapped potential:IRB guidance for the ethical research use of stored biological materials[J]. Irb, 2004, 26(4):1-8.
[20]
Ploug T, Holm S. Going beyond the false dichotomy of broad or specific consent:a meta-perspective on participant choice in research using human tissue[J]. Am J Bioeth, 2015, 15(9):44-46.DOI:10.1080/15265161.2015.1062178.
[21]
Ploug T, Holm S. Meta consent:a flexible and autonomous way of obtaining informed consent for secondary research[J]. BMJ, 2015, 350:h2146.DOI:10.1136/bmj.h2146.
[22]
Ploug T, Holm S. Meta consent - a flexible solution to the problem of secondary use of health data[J]. Bioethics, 2016, 30(9):721-732.DOI:10.1111/bioe.12286.
[23]
Ploug T, Holm S. The biobank consent debate:why ‘meta-consent’ is still the solution[J]. J Med Ethics, 2019, 45(5):295-297.DOI:10.1136/medethics-2018-105258.
[24]
石宇辉, 姚海嵩, 张小燕, 等. 医疗卫生机构生物样本库样本及信息采集泛知情同意书示范[J]. 中国医药生物技术, 2025, 20(S1):45-49.DOI:10.3969/j.issn.1673-713X.2025.suppl1.009.
[25]
满秋红, 薛江莉, 杨亚军. 生物样本库知情同意书规范化设计[J]. 协和医学杂志, 2019, 10(1):77-80.DOI:10.3969/j.issn.1674-9081.2019.01.012.
[26]
Beskow LM, Dombeck CB, Thompson CP, et al. Informed consent for biobanking:consensus-based guidelines for adequate comprehension[J]. Genet Med, 2015, 17(3):226-233.DOI:10.1038/gim.2014.102.

Footnotes

利益冲突 所有作者声明无利益冲突

PDF(923 KB)

Accesses

Citation

Detail

Sections
Recommended

/